StocksMedium•16 November 2026•
1 min read
INVO Fertility Clinic Revenues Surge 28% in Q3 2026
Key Facts
1INVO Fertility reported a 28% growth in clinic revenues for the third quarter of 2026.
2The company achieved its seventh consecutive quarter of positive Clinic-Level Adjusted EBITDA.
INVO Fertility reported a 28% growth in clinic revenues for the third quarter of 2026. GlobeNewswire reported that the company achieved its seventh consecutive quarter of positive Clinic-Level Adjusted EBITDA, highlighting sustained operational profitability.
The growth was driven by a combination of organic expansion and strategic acquisitions, alongside improvements in the balance sheet through debt repayment. IVF shares closed at $2.6 on November 13, 2026, with the stock trading between a day low of $2.6 and a high of $2.77.